Treatment of intracranial aneurysms with the Enterprise stent: a multicenter registry

Clinical article

Restricted access


The development of self-expanding stents dedicated to intracranial use has significantly widened the applicability of endovascular therapy to many intracranial aneurysms that would otherwise have been untreatable by endovascular techniques. Recent Food and Drug Administration approval of the Enterprise Vascular Reconstruction Device and Delivery System (Cordis) has added a new option for self-expanding stent-assisted intracranial aneurysm coiling.


The authors established a collaborative registry across multiple institutions to rapidly provide largevolume results regarding initial experience in using the Enterprise in real-world practice. Ten institutions (University at Buffalo, Thomas Jefferson University, University of Florida, Cleveland Clinic, Northwestern University, West Virginia University, University of Puerto Rico, Albany Medical Center Hospital, the Neurological Institute of Savannah, and the Barrow Neurological Institute) have provided consecutive data regarding their initial experience with the Enterprise.


In total, 141 patients (119 women) with 142 aneurysms underwent 143 attempted stent deployments. The use of Enterprise assistance with aneurysm coiling was associated with a 76% rate of ≥ 90% occlusion. An inability to navigate or deploy the stent was experienced in 3% of cases, as well as a 2% occurrence of inaccurate deployment. Procedural data demonstrated a 6% temporary morbidity, 2.8% permanent morbidity, and 2% mortality (0.8% unruptured, 12% ruptured).


The authors report initial results of the largest series to date in using the Enterprise for intracranial aneurysm treatment. The Enterprise is associated with a high rate of successful navigation and low occurrence of inaccurate stent deployment. The overall morbidity and mortality rates were low; however, caution should be exercised when considering Enterprise deployment in patients with subarachnoid hemorrhage as the authors' experience demonstrated a high rate of associated hemorrhagic complications leading to death.

Abbreviations used in this paper: FDA = Food and Drug Administration; HDE = Humanitarian Device Exemption; ICA = internal carotid artery; ICH = intracerebral hemorrhage; SAH = subarachnoid hemorrhage.

Article Information

Address correspondence to: Elad I. Levy, M.D., Department of Neurosurgery, University at Buffalo, Millard Fillmore Gates Hospital, Kaleida Health, 3 Gates Circle, Buffalo, New York 14209.

Current address for Drs. Liebman and Veznedaroglu: Stroke and Cerebrovascular Center of New Jersey, Hamilton, New Jersey.

Current address for Dr. Fiorella: Barrow Neurological Institute, Phoenix, Arizona.

Please include this information when citing this paper: published online October 31, 2008; DOI: 10.3171/2008.7.JNS08322.

© AANS, except where prohibited by US copyright law.




Akpek SArat AMorsi HKlucznick RPStrother CMMawad ME: Self-expandable stent-assisted coiling of widenecked intracranial aneurysms: a single-center experience. AJNR Am J Neuroradiol 26:122312312005


Bendok BRParkinson RJHage ZAAdel JGGounis MJ: The effect of vascular reconstruction device-assisted coiling on packing density, effective neck coverage, and angiographic outcome: an in vitro study. Neurosurgery 61:8358412007


Benitez RPSilva MTKlem JVeznedaroglu ERosenwasser RH: Endovascular occlusion of wide-necked aneurysms with a new intracranial microstent (Neuroform) and detachable coils. Neurosurgery 54:135913682004


Biondi AJanardhan VKatz JMSalvaggio KRiina HAGobin YP: Neuroform stent-assisted coil embolization of wide-neck intracranial aneurysms: strategies in stent deployment and midterm follow-up. Neurosurgery 61:4604692007


Fiorella DAlbuquerque FCDeshmukh VRMcDougall CG: Usefulness of the Neuroform stent for the treatment of cerebral aneurysms: results at initial (3–6-mo) follow-up. Neurosurgery 56:119112022005


Fiorella DAlbuquerque FCHan PMcDougall CG: Preliminary experience using the Neuroform stent for the treatment of cerebral aneurysms. Neurosurgery 54:6172004


Fiorella DAlbuquerque FCWoo HRasmussen PAMasaryk TJMcDougall CG: Neuroform in-stent stenosis: incidence, natural history, and treatment strategies. Neurosurgery 59:34 422006


Food and Drug Administration: Cordis Enterprise Vascular Reconstruction Device and Delivery System. New Humanitarian Device Approval. H-60001. HUD Number: 04-0147 ( [Accessed 9 April 2008]


Gallas SDrouineau JGabrillargues JPasco ACognard CPierot L: Feasibility, procedural morbidity and mortality, and long-term follow-up of endovascular treatment of 321 unruptured aneurysms. AJNR Am J Neuroradiol 29:63682008


Higashida RTHalbach VVDowd CFJuravsky LMeagher S: Initial clinical experience with a new self-expanding nitinol stent for the treatment of intracranial cerebral aneurysms: the Cordis Enterprise stent. AJNR Am J Neuroradiol 26:1751 17562005


International Study of Unruptured Intracranial Aneurysms Investigators: Unruptured intracranial aneurysms—risk of rupture and risks of surgical intervention. N Engl J Med 339:172517331998


Jabbour PKoebbe CVeznedaroglu EBenitez RPRosenwasser R: Stent-assisted coil placement for unruptured cerebral aneurysms. Neurosurg Focus 17:5E102004


Katsaridis VPapagiannaki CViolaris C: Embolization of acutely ruptured and unruptured wide-necked cerebral aneurysms using the Neuroform2 stent without pretreatment with antiplatelets: a single center experience. AJNR Am J Neuroradiol 27:112311282006


Kim MLevy EIMeng HHopkins LN: Quantification of hemodynamic changes induced by virtual placement of multiple stents across a wide-necked basilar trunk aneurysm. Neurosurgery 61:130513132007


Lee YJKim DJSuh SHLee SKKim JKim DI: Stent-assisted coil embolization of intracranial wide-necked aneurysms. Neuroradiology 47:6806892005


Lylyk PFerrario APasbon BMiranda CDoroszuk G: Buenos Aires experience with the Neuroform self-expanding stent for the treatment of intracranial aneurysms. J Neurosurg 102:2352412005


Weber WBendszus MKis BBoulanger TSolymosi LKuhne D: A new self-expanding nitinol stent (Enterprise) for the treatment of wide-necked intracranial aneurysms: initial clinical and angiographic results in 31 aneurysms. Neuroradiology 49:5555612007


Wiebers DOWhisnant JPHuston J IIIMeissner IBrown RD JrPiepgras DG: Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 362:1031102003


Yahia AMGordon VWhapham JMalek ASteel JFessler RD: Complications of Neuroform stent in endovascular treatment of intracranial aneurysms. Neurocrit Care 8:19302008


Cited By



All Time Past Year Past 30 Days
Abstract Views 118 118 51
Full Text Views 167 167 9
PDF Downloads 112 112 6
EPUB Downloads 0 0 0


Google Scholar